GL1X · GenesisL1 explorer

MolNFT v1 · #151288 · protein

Trypanosoma cruzi proline racemase in complex with inhibitor ng-P27

6HJE · Proline racemase a: “Trypanosoma cruzi proline racemase in complex with inhibitor ng-P27”. X-ray diffraction, 2 ligands (7N0, PO4), 7 pockets (best druggability 0.75). MolNFT v1 #151288 on GenesisL1: 3D structure, binding sites and…

PDB
6HJE
Type
protein
Length
713 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Proline racemase a
EC
5.1.1.4
UniProt
Q4DA80
Ligands
7N0, PO4
Pockets
7 · best druggability 0.75

Structure

x-ray diffraction · 2 distinct chains · 19% helix, 39% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProline racemase a (EC 5.1.1.4)protein35719% helix, 38% strandQ4DA80
BProline racemase a (EC 5.1.1.4)protein35620% helix, 40% strandQ4DA80

Ligands and binding sites

  • 7N0 · 2-[(1~{S})-2-oxidanylidenecyclopentyl]ethanoic acid · ligand · 2 copies · chains A, B
  • PO4 · Phosphate ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16040.750.8236empty
21880.600.82347N0
3790.500.8418empty
4520.430.8317empty
5650.370.7815empty

Interfaces

1 interface between chains.

  • A–B · 1681 Ų buried · 20 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Compared structures

  • 6HJE · Trypanosoma cruzi proline racemase in complex with inhibitor NG-P27 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q4DA80 · AlphaFold monomer V2.0 prediction for proline racemase a (Q4DA80) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.